Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure [Structural Heart Disease]

Conclusions— Redo TAVR for the treatment of postprocedural and late occurrence of paravalvular regurgitation and transcatheter aortic valve prosthesis failure seems to be safe, and it is associated with favorable acute and midterm clinical and echocardiographic outcomes.

http://circinterventions.ahajournals.org/cgi/content/short/9/9/e003930?rss=1

Source: Circulation: Cardiovascular Interventions - August 29, 2016 Category: Cardiology Authors: Barbanti, M., Webb, J. G., Tamburino, C., Van Mieghem, N. M., Makkar, R. R., Piazza, N., Latib, A., Sinning, J.-M., Won-Keun, K., Bleiziffer, S., Bedogni, F., Kapadia, S., Tchetche, D., Rodes-Cabau, J., Fiorina, C., Nombela-Franco, L., De Marco, F., de Ja Tags: Aortic Valve Replacement/Transcatheter Aortic Valve Implantation Structural Heart Disease Source Type: research